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Background: In the ultrahigh molecular weight polyethylene (UHMWPE) prosthetic environment, fibroblasts affected by
wear particles have the capacity of osteogenesis to reduce osteolysis. We aimed to assess the effects of macrophages on
the osteogenic capability of fibroblasts treated with UHMWPE wear particles.
Methods: The effect of different concentrations of UHMWPE (0, 0.01, 0.1, and 1mg/ml, respectively) on macrophage
proliferation were validated by MTT assay to determine the optimum one. The fibroblasts viability was further determined
in the co-culture system of UHMWPE particles and macrophage supernatants. The experiment was designed as seven
groups: (A) fibroblasts only; (B) fibroblasts + 1mg/ml UHMWPE particles; and (C1–C5) fibroblasts + 1/16, 1/8, 1/4, 1/2, and
1/1 supernatants of macrophage cultures stimulated by 1mg/ml UHMWPE particles vs. fibroblast complete media,
respectively. Alizarin red staining was used to detect calcium accumulation. The expression levels of osteogenic proteins
were detected by Western blot and ELISA, including alkaline phosphatase (ALP) and osteocalcin (OCN).
Results: The concentration of 0.1 mg/ml was considered as the optimum concentration for macrophage proliferation
due to the survival rate and was highest among the four concentrations. Fibroblast viability was better in the group of
fibroblasts + 1/16 ratio of macrophage supernatants stimulated by 1mg/ml of UHMWPE particles than the other
groups (1:8, 1:4, 1:2, 1:1). ALP and OCN expressions were significantly decreased in the group of fibroblasts + 1/4, 1/2,
and 1/1 supernatants stimulated by 1mg/ml of UHMWPE particles compared with other groups (1/8, 1/16) and the
group of fibroblasts + 1mg/ml UHMWPE (p < 0.5).
Conclusions: Macrophages are potentially involved in the periprosthetic osteolysis by reducing the osteogenic
capability of fibroblasts treated with wear particles generated from UHMWPE materials in total hip arthroplasty.
Keywords: Ultrahigh molecular weight polyethylene, Wear particles, Fibroblast, Macrophage, Osteogenesis, OsteolysisIntroduction
Periprosthetic osteolysis provoking aseptic loosening of
the implant results in the failure of total hip arthroplasty
(THA) and boosts a requirement of revision surgery [1].
Ultrahigh molecular weight polyethylene (UHMWPE)
has been widely used as prosthesis materials for total
joint replacements due to its excellent biocompatibility,© The Author(s). 2019 Open Access This artic
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ties [2]. Wear-generated particle debris promotes peripros-
thetic osteolysis, which is referred to as the progressive
insidious bone resorption [3]. The prosthesis wear particles
in the interfacial membrane (bone/prosthesis interface)
stimulate various cell types in the periprosthetic area, such
as macrophages and fibroblasts, leading to osteolysis [1].
Previous studies reported that interface membrane fibro-
blasts, affected by inflammatory cytokines, especially by
wear particles, significantly contribute to osteoclast genesis
and periprosthetic osteolysis [4, 5]. Many researchers havele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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thetic osteolysis by actively phagocytosing wear particles
and produce inflammatory cytokines, leading to the imbal-
ance of osteoclastic bone resorption and osteoblastic bone
formation [6–8].
Macrophage is one of the major cell components in
the prosthetic milieu and plays a critical role in the
different foreign body responses. During the process
of phagocytosis, macrophages released prostaglandins,
cytokines, metalloproteinases, and lysosomal enzymes
by wear particle stimulation which leads to activation
of bone resorbing pathways [9, 10]. Macrophages
were also reported to enhance osteogenesis of mouse
clonal osteoblast-like cells (MC3T3) in vitro in the
presence of calcium silicate cement via the bone
morphogenetic protein-2 (BMP2) signaling pathway
[11, 12]. So far, most studies focus on the effect of
UHMWPE particles on macrophage secretions [13,
14]. The effects of macrophages on fibroblasts in-
duced by UHMWPE particles remain unclear. As pre-
viously reported, the secretion of macrophages plays an
important role in enhancing osteogenesis of fibroblasts
[12]. Our previous results demonstrated that fibroblasts
derived from the synovial membrane can be converted
into osteoblasts by UHMWPE wear particles [15]. We
proposed a hypothesis that macrophages participate in the
periprosthetic osteolysis process by reducing the osteo-
genic capability of fibroblasts treated with UHMWPE
wear particles. In the present study, we investigate the role
of macrophage secretion on the in vitro biological activ-
ities of fibroblasts, especially the osteogenic capability,
upon the stimulation by the UHMWPE wear particles.
Materials and methods
Fibroblasts and macrophage cultures
Fibroblasts were isolated from the hip synovial membrane
of patients with femoral neck fracture during THA. Fibro-
blasts were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) containing 100U/mL penicillin and 100 μg/mL
streptomycin supplemented with 20% heat-inactivated fetal
bovine serum (FBS) (Gibco, USA). Murine macrophage cell
line Ana-1 (GNM2, Cell bank, China) were cultured in
RPMI-1640 (Gibco, NY, Grand Island, USA) supplemented
with 1.5 g/L NaHCO3, 2.5 g/L glucose, 0.11 g/L sodium
pyruvate, and 10% FBS at 37 °C, 5% CO2.
Preparation of UHMWPE particles
UHMWPE particles with an average diameter of
6.54 μm± 4.43 μm were prepared using a ball milling
technique and imaged by scanning electron microscope
(SEM, Quanta-200, FEI, Netherlands). UHMWPE wear
particles in diameters of 53–75 μm were purchased from
Sigma-Aldrich, USA. UHMWPE particles could mimic
UHMWPE lining separated during the artificial hiprevision procedures, which were analyzed and identified
by using Raman spectrometer (HORIBA JobinYvon
S.A.S, France). All the procedures were performed as pre-
viously reported [15]. Informed consent was obtained
from all patients. The study was approved by the Ethics
Committee of XiangYa Hospital, Central South University,
China. The procedures were performed in accordance
with the international ethics standards of human trials.3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay
To determine the proliferation of macrophages in differ-
ent concentrations of UHMWPE particles and to explore
the optimum concentration, MTT assay was adopted to
detect the cell viability [16]. Macrophages of logarithmic
growth phase were seeded in a 96-well plate at a density
of 1 × 104 cells/100 μl per well. Various concentrations of
UHMWPE particles (0, 0.01, 0.1, and 1mg/ml) were incu-
bated with macrophages for 24 h at 37 °C in a humidified
incubator at the atmosphere of 5% CO2. Macrophages
without UHMWPE particles were treated as the negative
control. Serum-free medium (100 μl) and 5mg/ml MTT
(20 μl, Sigma, USA) was further added into each well and
subsequently incubated for 4 h. Following the removal of
supernatant, the insoluble formazan crystals were
dissolved in 150 μl dimethyl sulfoxide (DMSO), and
absorbance at days 1, 3, 5, and 7 was measured by micro-
plate reader (Bio-Rad, USA) at the 570-nm wavelength.
Cell survival rate is (%) = [OD (particle-treated group)/OD
(control)] × 100%.
To investigate the effect of macrophages treated by 1
mg/ml UHMWPE particles on the viability of fibro-
blasts, the supernatant was collected at 48 h. According
to the different proportions of macrophage supernatants
vs. fibroblast media, the co-culture system was divided
into seven groups as follows: (A) fibroblasts only, (B) fi-
broblasts + 1 mg/ml UHMWPE particles, and (C1–C5)
fibroblasts + 1/16, 1/8, 1/4, 1/2, and 1/1 of macrophage
supernatants stimulated by 1 mg/ml of UHMWPE parti-
cles, respectively. The ratios of 1/16, 1/8, 1/4, 1/2, and
1/1 were defined as the proportion of macrophage
supernatants vs. fibroblast complete media. MTT assays
were performed as previously mentioned.Alizarin red staining
To explore the effect of macrophage secretion on fibro-
blast osteogenic differentiation, alizarin red staining was
used to detect the matrix mineralization, a process that
occurs at the later stages of bone formation in all groups.
In brief, cell specimens were washed with PBS and were
fixed in 95% ethanol for 10min. The sections were stained
by alizarin red solution [17].
Fig. 1 Viability of macrophages treated with different concentrations of
UHMWPE particles at days 1, 3, 5, and 7. One asterisk indicates p < 0.05,
two asterisks indicate p< 0.01, and three asterisks indicate p < 0.001
between two groups
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Extracted protein was harvested at day 5 from the following
co-culture systems: (A) fibroblasts only, (B) fibroblasts + 1
mg/ml UHMWPE particles, and (C1) fibroblasts + 1/16
macrophage supernatants stimulated by 1mg/ml of
UHMWPE particles. The protein was extracted with RIPA
lysis buffer with phenylmethylsulfonyl fluoride (PMSF). The
total protein was quantified by using a BCA Protein Assay
kit (Thermo Scientific, USA) according to the manufac-
turer’s instructions [18]. Thereafter, 50 μg of extracted pro-
tein was boiled at 99 °C for 5min in 1 × loading buffer and
chilled down on ice. The electrophoresis was performed in
10% SDS-PAGE gels and then transferred onto polyvinyli-
dene difluoride (PVDF) membranes. Non-specific binding
was blocked by incubating with 5% fat-free milk in TBST
buffer. After blocking the nonspecific sites with a blocking
solution, the primary antibodies were incubated overnight
at 4 °C, including anti-alkaline phosphatase (ALP) (1:10000,
Abcam, ab133602, USA), anti-osteocalcin (OCN) (1:400;
Santa Cruz, sc-74495, USA), and anti-GAPDH (1:800;
Santa Cruz, sc-365062, USA). Subsequently, the mem-
branes were washed with PBST followed by incubation
with secondary goat anti-rabbit or goat anti-mouse horse-
radish peroxidase (HRP)-conjugated antibodies (Sigma,
USA) for 1 h at room temperature. The blots were de-
tected by an enhanced chemiluminescence (ECL) reagent
(Pierce, USA). Bands were quantified by using the soft-
ware of Gel-pro Analyzer 4.0.
Enzyme-linked immunosorbent assay (ELISA)
Serum-free DMEM was used for determining the OCN
and ALP in the following co-culture systems: (A)
fibroblasts only, (B) fibroblasts + 1mg/ml UHMWPE par-
ticles, and (C1) fibroblasts + 1/16 supernatants stimulated
by 1mg/ml UHMWPE particles. OCN were assessed by
enzyme-linked immunosorbent assay kit (SEA471Hu,
Cloud-Clone Corp, USA). ALP activity was quantified by
ELISA kit (SEB472Hu, Cloud-Clone Corp, USA) accord-
ing to the instructions of the manufacturers. The optical
densities (OD) were determined using a plate reader at
450 nm as previously reported [11, 19].
Statistical analysis
All quantitative data were expressed as the mean ± stand-
ard deviation (SD). Statistical analysis was performed with
SPSS 17.0 software. Mean comparison was detected using
one-way analysis of variance (ANOVA, n = 3), and p <
0.05 was considered statistically significant.
Results
A higher survival rate of macrophage at lower
concentration of UHMWPE particles
Cell viability of macrophages was determined in the dif-
ferent concentrations of UHMWPE particles (Fig. 1).There was no statistical difference in the survival rate of
macrophages between treated with 0.01 mg/ml
UHMWPE particles and UHMWPE free controls at days
1, 3, 5, 7. However, there were significant differences in
both macrophages + 0.1 mg/ml UHMWPE particles
group and macrophages + 1mg/ml UHMWPE particles
group compared to macrophages only group (p < 0.01).
In addition, the survival rate of macrophages was higher
in macrophages + 0.1 mg/ml UHMWPE particles group
than that in macrophages + 1mg/ml UHMWPE particles
group (p < 0.05). The results revealed that 0.1 mg/ml
UHMWPE particles was the optimum concentration
that stimulated for macrophage proliferation (Fig. 1).Macrophage supernatant in the existence of UHMWPE
particles reduced fibroblast survival rate
It is obvious that the survival rate of fibroblast was sig-
nificantly higher in fibroblasts + 1mg/ml UHMWPE
particles group than that in fibroblasts with only control
group (p < 0.001, group A vs. B). Cell viability of fibro-
blasts treated with 1 mg/ml UHMWPE particles was
reduced as supernatants from macrophage cultures
treated with 1 mg/ml of UHMWPE particles were added
to the culture media (p < 0.01, Fig. 2a). Fibroblast sur-
vival rate was gradually decreased as the ratio of the
macrophage supernatants increased. The results showed
that proliferated or survived fibroblasts were better in the
group of 1/16 macrophage supernatants from co-culture
with 1mg/ml of UHMWPE particles compared to other
macrophage supernatant proportions accounting for
fibroblasts’ complete media (p < 0.01, Fig. 2b).
Fig. 2 Macrophage supernatants’ effect on the viability of fibroblasts treated with 1mg/ml UHMWPE particles at day 5. Two asterisks indicate p < 0.01,
three asterisks indicate p < 0.001 versus A (fibroblasts only); Two number signs indicate p < 0.01, three number signs indicate p < 0.001 versus B
(fibroblasts + 1mg/ml UHMWPE particles). a. fibroblasts only; b. fibroblasts + 1 mg/ml UHMWPE particles; C1-C5. fibroblasts + 1/16, 1/8, 1/4, 1/2, 1/1 of
macrophage supernatants stimulated by 1mg/ml of UHMWPE particles, respectively
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wear particles reduced osteogenic capacity of fibroblasts
Calcium accumulation (red aggregate deposition) was
more pronounced in the fibroblasts + 1mg/ml UHMWPE
particles group compared to fibroblasts with only con-
trol group. However, the staining intensity gradually de-
creased as the ratio of macrophage supernatants
increased (Fig. 3).
Macrophage supernatant upon the existence of UHMWPE
wear particles reduced osteogenic protein secretion of
fibroblasts
Protein expressions of the earlier osteogenic marker
ALP and the late osteogenic markers OCN protein were
obviously enhanced in fibroblasts + 1 mg/ml UHMWPE
particles group compared to control group (fibroblastsFig. 3 Alizarin red staining of fibroblast treated with UHMWPE particles andonly). However, the expression of the ALP and OCN
protein gradually decreased as the ratio of macrophage
supernatants vs. fibroblast completed media increased
(Fig. 4a). ELISA results confirmed that the expressions
of ALP and OCN were slightly reduced in fibroblasts +
1/16 and 1/8 macrophage supernatants group compared
with fibroblasts + 1 mg/ml UHMWPE particles group
(p > 0.05, Fig. 4b); however, a significant decrease was
found while 1/4, 1/2, and 1/1 macrophage supernatants
were added compared with fibroblasts + 1 mg/ml
UHMWPE particles group (p < 0.05).
Discussion
Periprosthetic osteolysis, followed by implant loosening,
is induced by UHMWPE wear particles and results in
the failure of THA and the necessity of total jointadded with macrophage supernatants (× 40)
Fig. 4 Osteogenic protein level of fibroblasts treated with UHMWPE particles and added with macrophage supernatants. a Western blot, b ELISA. One
asterisk indicates p< 0.05, two asterisks indicate p < 0.01, three asterisks indicate p < 0.001 versus A (fibroblasts only); one number sign indicates p < 0.05,
two number signs indicate p < 0.01, three number sign indicate p < 0.001 versus B (fibroblasts + 1mg/ml UHMWPE particles). One plus sign indicates p
< 0.05, two plus signs indicate p< 0.01, three plus signs indicate p < 0.001 versus C1 (fibroblasts + 1mg/ml UHMWPE particles + 1/16 macrophage
supernatants vs. fibroblast media)
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proximately 10–50% of all revision THA can be attributed
to periprosthetic osteolysis [21]. Wear debris, generated by
articulating motion at the bearing surfaces, induces pro-
gressive osteolysis by increasing bone resorption and sup-
pressing bone formation [22, 23]. Therefore, it is urgently
essential to address the problem for the patients with
end-stage osteoarthritis, avascular necrosis of the hip, or
femoral neck fractures in THA [24]. The purpose of this
study is to assess the effects of macrophages on the osteo-
genic capability of fibroblasts treated with UHMWPE wear
particles. Our results confirmed that macrophages partici-
pate in the periprosthetic osteolysis process by reducing
the osteogenic capability of fibroblasts treated with
UHMWPE wear particles, and involved in the implant
loosening. Currently, a variety of cells have been identified
in the periprosthetic interfacial membrane (bone-implant
interface), such as histiocytes, fibroblasts, endothelial cells,
lymphocytes, osteoblasts, osteoclasts, and macrophages,
while synovial-like membrane mainly consists of macro-
phages and fibroblasts [25, 26].
Our previous study demonstrated that fibroblasts
stimulated by UHMWPE wear particles (1 mg/ml) have
the capacity of forming osteoblast to reduce osteolysis
[15]. It provided favorable evidence for clinical use of
UHMWPE as prosthesis in THA as reported by other
literature [27, 28]. It is well known that the macrophage
response to UHMWPE wear debris plays a critical role
in the long-term periprosthetic osteolysis [29]. Prosthetic
particles, produced by wear at the articulating surface of
prostheses are phagocytosed by macrophages [30]. This
study was designed to investigate how macrophagesparticipate in the processes of fibroblasts to osteoblast
by stimulating UHMWPE wear particles.
Osteoblasts play a critical role in periprosthetic osteoly-
sis, as normal bone metabolism commonly relies on the
balance between bone formation and degradation, and
either increased bone resorption or decreased bone for-
mation can lead to the loss of bone stock [31]. Wear parti-
cles have been presented to exert a negative effect on
osteoblasts during the process of osteolysis. In our work,
fibroblasts were successfully separated from the hip syn-
ovial membrane during THA or revision procedures, and
UHMWPE particles with desired sizes (average diameter
6.54 μm± 4.43 μm) and various shapes were prepared
through micro-grinding procedures. MTT results indi-
cated that the survival rate of macrophages was signifi-
cantly higher when it was treated with 0.1mg/ml
UHMWPE particles. Findings of the present study are
consistent with Zaveri et al. [32] who reported that the
optimum proliferation effect of fibroblasts for co-culture
was stimulated by 0.1mg/ml UHMWPE particles. A study
by an American reported that the RAW264.7 cells with a
density of 1 × 105/mL were most sensitive to the 0.1 mg/
mL concentration of UHMWPE [33]. Macrophages are
responsible for mediating foreign body immune reaction
to wear particles from joint replacements [26]. Many stud-
ies reported that UHMWPE wear particles induced
macrophage infiltration and inflammation leading to peri-
prosthetic osteolysis through secreting inflammatory
cytokines [29, 34]. According to the proportion of macro-
phage supernatants in fibroblast complete media, the
co-culture system was divided into seven groups, besides
the fibroblasts only group and fibroblasts + 1mg/ml
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that fibroblasts treated with 1mg/ml UHMWPE particles
containing 1/16 of the corresponding macrophage super-
natants had the highest cell viability among the macro-
phage supernatant treatment groups. We tried to mimic
the effective joint space environment by culture of the
fibroblasts with macrophage supernatants and UHMWPE
wear particles. To date, methods for the treatment of wear
debris-induced osteolysis have focused on the inhibition
of inflammation and target osteoclasts [35]. ALP is a trad-
itional marker of osteoblast differentiation and is related
to the production of a mineralized osteoblast [36]. The
Western blot and ELISA analysis were combined to ex-
plore the osteogenic ability of fibroblasts in the protein
level, with mainly focusing on the ALP and OCN. Our re-
sults suggested that the osteogenic ability of fibroblasts
treated with 1mg/ml UHMWPE particles was reduced by
adding macrophage supernatants to fibroblast complete
media, just as the alizarin red staining showed. Wang
et al. suggested that a lower expression of ALP and OCN
in osteoprogenitor cells stimulated with Ti particles [37].
However, there are several limitations to our study.
First is to mimic the effective joint space environment
scenario. However, it has been demonstrated that these
particles induced osteolysis around the prosthetic
implant by mechanisms similar to polyethylene particles.
An animal model study with continuous particle gener-
ation would provide a better conclusion in the future.
Conclusions
Thus, based on the data presented, we speculated that
macrophages participate in the periprosthetic osteolysis
process by reducing the osteogenic capability of fibroblasts
treated with UHMWPE wear particles and involved in the
implant loosening. This work strengthened our under-
standing about the complex bone-implant microenviron-
ment in total hip arthroplasty.
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